Nhận Dạng Quốc Tế & Đặc Tính Hóa Học
								
																		
									
																											
																		
									
																											
																		
									
										
											Monoisotopic mass 
										
										
											285.103478791										
									 
																											
									
																		
									
										
											InChI 
										
										
											InChI=1S/C13H19NO4S/c1-3-9-14(10-4-2)19(17,18)12-7-5-11(6-8-12)13(15)16/h5-8H,3-4,9-10H2,1-2H3,(H,15,16)										
									 
																		
																		
										
											InChI Key 
										
										
											InChIKey=DBABZHXKTCFAPX-UHFFFAOYSA-N										
									 
																											
																		
										
											IUPAC Name 
										
										
											4-(dipropylsulfamoyl)benzoic acid										
									 
																											
																		
										
											Traditional IUPAC Name 
										
										
											probenecid										
									 
																											
									
																		
										
											SMILES 
										
										
											CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O										
									 
																		
																		
									
																		
																		
																		
																		
																		
																											
																		
																											
																		
																											
																		
										
											pKa (strongest acidic) 
										
										
											3.53										
									 
																											
																		
																		
																											
																		
										
											Refractivity 
										
										
											73.81 m3·mol-1
										
									 
																			  
		  
																		
																											
																		
																		
									
																		
																		
																		
																		
																		
																		
																		
																		
																		
											  
		  
								 
							 	
														
															
								 Dược Lực Học : 
								
									Probenecid is a uricosuric and renal tubular blocking agent and is used in combination with colchicine to treat chronic gouty arthritis when complicated by frequent, recurrent acute attacks of gout. It inhibits the reabsorption of urate at the proximal convoluted tubule, thus increasing the urinary excretion of uric acid and decreasing serum urate levels. Effective uricosuria reduces the miscible urate pool, retards urate deposition, and promotes resorption of urate deposits. At the proximal and distal tubles, probenecid competitively inhibits the secretion of many weak organic acids including penicillins, most cephalosporins, and some other β-lactam antibiotics. This results in an increase in the plasma concentrations of acidic drugs eliminated principally by renal secretion, but only a slight increase if the drug is eliminated mainly by filtration. Thus, the drug can be used for therapeutic advantages to increase concentrations of certain β-lactam antibiotics in the treatment of gonorrhea, neurosyphilis, or pelvic inflammatory disease (PID).									
							
														
															
								 Cơ Chế Tác Dụng : 
								
									The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy. [PubChem]								
								
									Probenecid inhibits the tubular reabsorption of urate, thus increasing the urinary excretion of uric acid and decreasing serum urate levels. Probenecid may also reduce plasma binding of urate and inhibit renal secretion of uric acid at subtherapeutic concentrations. The mechanism by which probenecid inhibits renal tubular transport is not known, but the drug may inhibit transport enzymes that require a source of high energy phosphate bonds and/or nonspecifically interfere with substrate access to protein receptor sites on the kidney tubules.								
							
														
															
								 Dược Động Học  : 
								
									
▧ Protein binding : 
75-95%
▧ Route of Elimination : 
Excreted principally in the urine as monoacyl glucuronide and unchanged drug. Alkalinization of urine increases renal probenecid excretion.
▧ Half Life : 
6-12 hours								
	
							 
														
														
							
																					
								 Chỉ Định : 
								
									For the reduction of serum uric acid concentrations in chronic gouty arthritis and tophaceous gout in patients with frequent disabling gout attacks. Has also been effectively used to promote uric acid excretion in hyperuricemia secondary to the administration of thiazide and related diuretics. 								
							
	
														
									
							
							
								 Tương Tác Thuốc : 
																
																		
									- 
										Acetylsalicylic acid
										
											Acetylsalicylic acid decreases the uricosuric effect of probenecid.										
									
- 
										Bismuth Subsalicylate
										
											The salicylate, bismuth subsalicylate, decreases the uricosuric effect of probenecid.										
									
- 
										Cefaclor
										
											Probenecid may increase the serum level of cefaclor.										
									
- 
										Cefadroxil
										
											Probenecid may increase the serum level of cefadroxil.										
									
- 
										Cefamandole
										
											Probenecid may increase the serum level of cefamandole.										
									
- 
										Cefazolin
										
											Probenecid may increase the serum level of cefazolin.										
									
- 
										Cefepime
										
											Probenecid may increase the serum level of cefepime.										
									
- 
										Cefixime
										
											Probenecid may increase the serum level of cefixime.										
									
- 
										Cefmetazole
										
											Probenecid may increase the serum level of cefmatzole.										
									
- 
										Cefonicid
										
											Probenecid may increase the serum level of cefonicib.										
									
- 
										Cefotaxime
										
											Probenecid may increase the serum level of cefotaxime.										
									
- 
										Cefotetan
										
											Probenecid may increase the serum level of cefotetan.										
									
- 
										Cefoxitin
										
											Probenecid may increase the serum level of cefoxitin.										
									
- 
										Cefprozil
										
											Probenecid may increase the serum level of cefprozil.										
									
- 
										Cefradine
										
											Probenecid may increase the serum level of cefradine.										
									
- 
										Ceftizoxime
										
											Probenecid may increase the serum level of ceftizoxime.										
									
- 
										Cefuroxime
										
											Probenecid may increase the serum level of cefuroxime.										
									
- 
										Cephalexin
										
											Probenecid may increase the serum level of cephalexin.										
									
- 
										Cephaloglycin
										
											Probenecid may increase the serum level of cephaloglycin.										
									
- 
										Cephalothin Group
										
											Probenecid may increase the serum level of cephalothin.										
									
- 
										Diflunisal
										
											Probenecid increases toxicity of diflunisal										
									
- 
										Ganciclovir
										
											Probenecid increases the effect and toxicity of ganciclovir/valganciclovir										
									
- 
										Glycerol Phenylbutyrate
										
											Probenecid may inhibit the renal excretion of metabolites of glycerol phenylbutyrate including PAGN and PAA.										
									
- 
										Indomethacin
										
											Probenecid increases the effect/toxicity of indomethacin										
									
- 
										Ketorolac
										
											Probenecid increases toxicity of ketorolac										
									
- 
										Loracarbef
										
											Probenecid may increase the serum level of loracarbef.										
									
- 
										Magnesium salicylate
										
											The salicylate, magnesium salicylate, decreases the uricosuric effect of probenecid.										
									
- 
										Methotrexate
										
											Probenecid increases the effect and toxicity of methotrexate										
									
- 
										Moxalactam Derivative
										
											Probenecid may increase the serum level of the moxalactam derivative.										
									
- 
										Pralatrexate
										
											Decreases renal clearance of pralatrexate thus increasing exposure. Monitor for adverse effects. 										
									
- 
										Salicylate-sodium
										
											The salicylate, salicylate-sodium, decreases the uricosuric effect of probenecid.										
									
- 
										Salsalate
										
											The salicylate, salsalate, decreases the uricosuric effect of probenecid.										
									
- 
										Silodosin
										
											Strong UGT2B7 inhibitors may increase levels of silodosin. Monitor concomitant therapy closely. 										
									
- 
										Tapentadol
										
											Increases the AUC of tapentadol by 57%. These changes are not considered clinically relevant and no change in dose is required.										
									
- 
										Trisalicylate-choline
										
											The salicylate, trisalicylate-choline, decreases the uricosuric effect of probenecid.										
									
- 
										Valganciclovir
										
											Probenecid may decrease excretion of Valganciclovir. Monitor for increased serum concentration and toxicity of Valganciclovir.										
									
- 
										Zidovudine
										
											Rash, malaise, myalgia										
									
 								
							
							
							
							
								
								 Liều Lượng & Cách Dùng : 
								
									Tablet - Oral - 500 mg								
							
	
							
														
														
							
																						
								 Dữ Kiện Thương Mại 
								
																											
										
											Giá thị trường
										
										
											
																							- 
													
													Giá bán buôn : USD >1.37 Đơn vị tính : tablet 
- 
													
													Giá bán buôn : USD >0.21 Đơn vị tính : tablet 
- 
													
													Giá bán buôn : USD >0.87 Đơn vị tính : tablet 
 
									 
																		
																											
										
											Nhà Sản Xuất
										
										
											
																							- 
													
													Sản phẩm biệt dược : Benecid 
- 
													
													Sản phẩm biệt dược : Benemid 
- 
													
													Sản phẩm biệt dược : Benuryl 
- 
													
													Sản phẩm biệt dược : Probalan 
- 
													
													Sản phẩm biệt dược : Probecid 
- 
													
													Sản phẩm biệt dược : Proben 
 
									 
																		
																											
											  
		  
								 
							 	
							
							
														
							
						
							
																													
								 Tài Liệu Tham Khảo Thêm 
								
																		
																		
																		
																		
																		
																		
																		
										
											National Drug Code Directory